These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7612175)

  • 21. Role of metabolic activation in the pathogenesis of chemically induced pulmonary disease: mechanism of action of the lung-toxic furan, 4-ipomeanol.
    Boyd MR
    Environ Health Perspect; 1976 Aug; 16():127-38. PubMed ID: 1017416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemically reactive intermediates and pulmonary xenobiotic toxicity.
    Gram TE
    Pharmacol Rev; 1997 Dec; 49(4):297-341. PubMed ID: 9443161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions of xenobiotics in the respiratory tract following non-inhalation routes of exposure.
    Brittebo EB; Brandt I
    Int J Epidemiol; 1990; 19 Suppl 1():S24-31. PubMed ID: 2258273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Xenobiotic metabolism by isolated pulmonary cells.
    Devereux TR; Domin BA; Philpot RM
    Pharmacol Ther; 1989; 41(1-2):243-56. PubMed ID: 2652151
    [No Abstract]   [Full Text] [Related]  

  • 25. The fate of foreign compounds in biological systems. ISSX/SOT North American Symposium on Endogenous Factors in the Toxicity of Xenobiotics. 8-13 November 1987, Clearwater, Florida. Proceedings.
    Xenobiotica; 1988 Nov; 18(11):1199-333. PubMed ID: 3245222
    [No Abstract]   [Full Text] [Related]  

  • 26. Curiosities in drug metabolism.
    Mitchell SC; Waring RH; Smith RL
    Xenobiotica; 2014 Jul; 44(7):666-76. PubMed ID: 24779638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification and characterization of xenobiotic-metabolizing enzymes from lung tissue.
    Guengerich FP
    Pharmacol Ther; 1990; 45(3):299-307. PubMed ID: 2405438
    [No Abstract]   [Full Text] [Related]  

  • 28. [Modern tumor therapy and its pulmonary side effects].
    Hellbach K
    Radiologe; 2021 Oct; 61(10):955-967. PubMed ID: 34550423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Building predictive in vitro pulmonary toxicity assays using high-throughput imaging and artificial intelligence.
    Lee JJ; Miller JA; Basu S; Kee TV; Loo LH
    Arch Toxicol; 2018 Jun; 92(6):2055-2075. PubMed ID: 29705884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carrier-mediated uptake of clonidine in cultured human lung cells.
    Le Vée M; Jouan E; Fardel O
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Apr; 391(4):361-369. PubMed ID: 29352450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of pulmonary sigma receptors by radioligand binding.
    Lever JR; Litton TP; Fergason-Cantrell EA
    Eur J Pharmacol; 2015 Sep; 762():118-26. PubMed ID: 26004528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Light-dark oscillations in the lung transcriptome: implications for lung homeostasis, repair, metabolism, disease, and drug action.
    Sukumaran S; Jusko WJ; Dubois DC; Almon RR
    J Appl Physiol (1985); 2011 Jun; 110(6):1732-47. PubMed ID: 21436464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of the superoxide dismutase (V16A) and catalase (C262T) genetic polymorphisms with the clinical outcome of patients with acute paraquat intoxication.
    Hong JR; Seok SJ; Jeong DS; Lee SG; Gil HW; Yang JO; Lee EY; Hong SY
    Korean J Intern Med; 2010 Dec; 25(4):422-8. PubMed ID: 21179281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Organic cation transport in rabbit alveolar epithelial cell monolayers.
    Shen J; Elbert KJ; Yamashita F; Lehr CM; Kim KJ; Lee VH
    Pharm Res; 1999 Aug; 16(8):1280-7. PubMed ID: 10468032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of the lung in accumulation and metabolism of xenobiotic compounds--implications for chemically induced toxicity.
    Foth H
    Crit Rev Toxicol; 1995; 25(2):165-205. PubMed ID: 7612175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of xenobiotic-metabolizing enzymes in human pulmonary tissue: possible role in susceptibility for ILD.
    Hukkanen J; Pelkonen O; Raunio H
    Eur Respir J Suppl; 2001 Sep; 32():122s-126s. PubMed ID: 11816819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex-dependent metabolism of xenobiotics.
    Mugford CA; Kedderis GL
    Drug Metab Rev; 1998 Aug; 30(3):441-98. PubMed ID: 9710703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
    Ozawa S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary disposition and effects of drugs on pulmonary removal of endogenous substances.
    Mehendale HM
    Fed Proc; 1984 Aug; 43(11):2586-91. PubMed ID: 6204891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lung metabolism of xenobiotic compounds.
    Duncan CA
    Clin Chest Med; 1989 Mar; 10(1):49-58. PubMed ID: 2468440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.